Biologic Reduces Asthma, COPD Exacerbations

By Debbie Bunch

September 21, 2026 | 2 min read

Two clinical trials that were conducted separately but published together by the New England Journal of Medicine and presented at the recent European Respiratory Society Congress suggest that COPD patients who receive the biologic tozorakimab may significantly reduce their risk of experiencing an ac…

This content is for AARC members only.

Become a Member

Read Abstract Read Article

Debbie Bunch

Debbie Bunch has a bachelor's degree in journalism from the University of North Texas and lives in Dallas, Texas. She has spent many years writing for the AARC on topics ranging from clinical innovations to management. In her spare time, she enjoys traveling, reading, photography, and spending time with friends, family, and her rescue pup Juju.

Share